[go: up one dir, main page]

FI955685L - Uusia tiatsolidiinidioneja ja näitä sisältäviä lääkkeitä - Google Patents

Uusia tiatsolidiinidioneja ja näitä sisältäviä lääkkeitä Download PDF

Info

Publication number
FI955685L
FI955685L FI955685A FI955685A FI955685L FI 955685 L FI955685 L FI 955685L FI 955685 A FI955685 A FI 955685A FI 955685 A FI955685 A FI 955685A FI 955685 L FI955685 L FI 955685L
Authority
FI
Finland
Prior art keywords
medicines containing
thiazolidinediones
new
new thiazolidinediones
medicines
Prior art date
Application number
FI955685A
Other languages
English (en)
Swedish (sv)
Other versions
FI955685A7 (fi
FI955685A0 (fi
Inventor
Alfred Mertens
Hans-Peter Wolff
Peter Freund
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of FI955685L publication Critical patent/FI955685L/fi
Publication of FI955685A7 publication Critical patent/FI955685A7/fi
Publication of FI955685A0 publication Critical patent/FI955685A0/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI955685A 1993-05-25 1994-05-19 Uusia tiatsolidiinidioneja ja näitä sisältäviä lääkkeitä FI955685A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4317320A DE4317320A1 (de) 1993-05-25 1993-05-25 Neue Thiazolidindione und diese enthaltende Arzneimittel
PCT/EP1994/001619 WO1994027995A1 (de) 1993-05-25 1994-05-19 Neue thiazolidindione und diese enthaltende arzneimittel

Publications (3)

Publication Number Publication Date
FI955685L true FI955685L (fi) 1995-11-24
FI955685A7 FI955685A7 (fi) 1995-11-24
FI955685A0 FI955685A0 (fi) 1995-11-24

Family

ID=6488833

Family Applications (1)

Application Number Title Priority Date Filing Date
FI955685A FI955685A0 (fi) 1993-05-25 1994-05-19 Uusia tiatsolidiinidioneja ja näitä sisältäviä lääkkeitä

Country Status (25)

Country Link
US (1) US5599826A (fi)
EP (1) EP0700397B1 (fi)
JP (1) JP3162721B2 (fi)
KR (1) KR100243783B1 (fi)
CN (1) CN1040324C (fi)
AT (1) ATE223409T1 (fi)
AU (1) AU682699B2 (fi)
CA (1) CA2163028C (fi)
CL (1) CL2004001167A1 (fi)
CY (1) CY2415B1 (fi)
CZ (1) CZ285927B6 (fi)
DE (2) DE4317320A1 (fi)
DK (1) DK0700397T3 (fi)
ES (1) ES2180581T3 (fi)
FI (1) FI955685A0 (fi)
HU (1) HU217065B (fi)
NO (1) NO307832B1 (fi)
NZ (1) NZ267410A (fi)
PL (1) PL180046B1 (fi)
PT (1) PT700397E (fi)
RO (1) RO114328B1 (fi)
RU (1) RU2122002C1 (fi)
SK (1) SK282618B6 (fi)
UA (1) UA41362C2 (fi)
WO (1) WO1994027995A1 (fi)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07138258A (ja) * 1993-11-16 1995-05-30 Taiho Yakuhin Kogyo Kk チアゾリジンジオン誘導体又はその塩
ATE236154T1 (de) * 1995-07-31 2003-04-15 Shionogi & Co Pyrrolydin-derivate mit einer phospholipase a2 inhibierenden wirkung
JPH09176162A (ja) * 1995-12-22 1997-07-08 Toubishi Yakuhin Kogyo Kk チアゾリジンジオン誘導体及びその製造法並びにそれを含む医薬組成物
DE19619819A1 (de) * 1996-05-16 1997-11-20 Boehringer Mannheim Gmbh Neue Thiazolidindione, Verfahren zu ihrer Herstellung und diese enthaltenden Arzneimittel
DE19711616A1 (de) * 1997-03-20 1998-09-24 Boehringer Mannheim Gmbh Verbessertes Verfahren zur Herstellung von Thiazolidindionen
DE19711617A1 (de) * 1997-03-20 1998-09-24 Boehringer Mannheim Gmbh Neue Thiazolidindione, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
US6028088A (en) * 1998-10-30 2000-02-22 The University Of Mississippi Flavonoid derivatives
GB9824893D0 (en) * 1998-11-12 1999-01-06 Smithkline Beckman Corp Novel method of treatment
WO2000030628A2 (en) * 1998-11-20 2000-06-02 Genentech, Inc. Method of inhibiting angiogenesis
DE60026404T2 (de) 1999-08-02 2006-10-19 F. Hoffmann-La Roche Ag Verfahren zur Herstellung von Benzothiophen-Derivaten
US6531609B2 (en) 2000-04-14 2003-03-11 Hoffmann-La Roche Inc. Process for the preparation of thiazolidinedione derivatives
PT1283830E (pt) * 2000-05-08 2008-08-18 Hoffmann La Roche Activadores da glucoquinase de fenilamida substituída com para-amino
MXPA02012583A (es) 2000-06-27 2003-04-10 Hoffmann La Roche Metodo para preparacion de una composicion.
CZ20031772A3 (cs) * 2000-12-25 2003-11-12 Ono Pharmaceutical Co., Ltd. Derivát dihydronaftalenu a činidlo obsahující tento derivát jako účinnou složku
CA2441941A1 (en) * 2001-04-06 2002-10-17 F. Hoffmann-La Roche Ag Thiazolidinediones alone or in combination with other therapeutic agents for inhibiting or reducing tumour growth
NZ529033A (en) 2001-05-15 2005-06-24 F Carboxylic acid substituted oxazole derivatives for use as PPAR-alpha and -gamma activators in the treatment of diabetes
JP2003040877A (ja) * 2001-07-24 2003-02-13 Sumika Fine Chemicals Co Ltd 5−[6−(2−フルオロベンジルオキシ)−2−ナフチル]メチル−2,4−チアゾリジンジオンの製造方法及びその精製方法
US7102000B2 (en) * 2002-03-08 2006-09-05 Incyte San Diego Inc. Heterocyclic amide derivatives for the treatment of diabetes and other diseases
ATE372990T1 (de) * 2002-07-03 2007-09-15 Hoffmann La Roche Oxazolderivat und deren verwendung als insulinsensibilisatoren
BR0313946A (pt) * 2002-08-30 2005-07-12 Hoffmann La Roche Compostos, processo para a manufatura destes compostos, composições farmacêuticas que compreendem os mesmos, métodos para o tratamento e/ou prevenção de enfermidades que são moduladas por agonistas ppara(alfa) e/ou ppary, utilização dos compostos e/ou do método
RU2296759C2 (ru) * 2002-09-12 2007-04-10 Ф.Хоффманн-Ля Рош Аг N-замещенные 1н-индол-5-пропионовые кислоты, фармацевтическая композиция, содержащая эти соединения, и их применение (варианты)
ES2312819T3 (es) * 2002-11-25 2009-03-01 F. Hoffmann-La Roche Ag Derivados de indolilo.
US7259176B2 (en) * 2003-06-26 2007-08-21 Hoffmann-La Roche Inc. Process for the preparation of the insulin sensitizer
CN101693202B (zh) * 2009-10-21 2011-04-20 沧州那瑞化学科技有限公司 盐酸吡咯列酮关键中间体加氢反应催化剂及加氢反应方法
US20150004144A1 (en) 2011-12-02 2015-01-01 The General Hospital Corporation Differentiation into brown adipocytes

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1003445B (zh) * 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物,其制备方法和用途
HU210339B (en) * 1985-05-21 1995-03-28 Pfizer Process for preparing thiazolidinediones and their pharmaceutical compositions haring hypoglycemic effect
GB8713861D0 (en) * 1987-06-13 1987-07-15 Beecham Group Plc Compounds
ATE104626T1 (de) * 1988-03-04 1994-05-15 Volk Inc Kurt H Gegenstand fuer den unmittelbaren versand per post mit einer postversandfaehigen antwortkarte.
WO1989008652A1 (en) * 1988-03-08 1989-09-21 Pfizer Inc. Thiazolidinedione derivatives as hypoglycemic agents
EP0533933A4 (en) * 1990-07-03 1993-05-05 Yamanouchi Pharmaceutical Co. Ltd. Bisheterocyclic compound
FR2688220A1 (fr) * 1992-03-06 1993-09-10 Adir Nouveaux derives de thiazolidine-2,4-dione, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
AU682699B2 (en) 1997-10-16
EP0700397B1 (de) 2002-09-04
CN1040324C (zh) 1998-10-21
RU2122002C1 (ru) 1998-11-20
US5599826A (en) 1997-02-04
HU217065B (hu) 1999-11-29
NO954762L (no) 1995-11-24
EP0700397A1 (de) 1996-03-13
NO954762D0 (no) 1995-11-24
CZ299995A3 (en) 1996-03-13
NO307832B1 (no) 2000-06-05
AU6970494A (en) 1994-12-20
PL311752A1 (en) 1996-03-18
SK146195A3 (en) 1996-06-05
SK282618B6 (sk) 2002-10-08
JPH08510456A (ja) 1996-11-05
PT700397E (pt) 2002-12-31
FI955685A7 (fi) 1995-11-24
NZ267410A (en) 1996-12-20
PL180046B1 (en) 2000-12-29
DE4317320A1 (de) 1994-12-01
CA2163028A1 (en) 1994-12-08
RO114328B1 (ro) 1999-03-30
KR100243783B1 (ko) 2000-03-02
HU9503376D0 (en) 1996-01-29
HUT75099A (en) 1997-04-28
CN1124488A (zh) 1996-06-12
KR960702460A (ko) 1996-04-27
DE59410181D1 (de) 2002-10-10
JP3162721B2 (ja) 2001-05-08
ES2180581T3 (es) 2003-02-16
ATE223409T1 (de) 2002-09-15
WO1994027995A1 (de) 1994-12-08
CL2004001167A1 (es) 2005-05-20
UA41362C2 (uk) 2001-09-17
CY2415B1 (en) 2004-11-12
DK0700397T3 (da) 2003-01-06
CA2163028C (en) 2003-11-25
CZ285927B6 (cs) 1999-11-17
FI955685A0 (fi) 1995-11-24

Similar Documents

Publication Publication Date Title
FI955685A7 (fi) Uusia tiatsolidiinidioneja ja näitä sisältäviä lääkkeitä
BR1100824A (pt) Composto e composição farmacêutica
FI942634A7 (fi) Lääkeruiskut ja menetelmät
FI945198L (fi) Farmaseuttiset ja muut annosmuodot
FI944310L (fi) Heteroaryyliamino- ja heteroaryylisuolfonamidosubstituoituja 3-bentsyyliaminometyylipiperidiinejä ja vastaavia yhdisteitä
FI945625L (fi) Indolokarbatsoli-imidit ja niiden käyttö
FI932103A7 (fi) Uusia 4-aryylipiperatsiineja ja 4-aryylipiperidiinejä
FI961599A7 (fi) 1N-alkyyli-N-aryylipyrimidiiniamiineja ja niiden johdannaisia
FI952825L (fi) Uudet taksoidit, niiden valmistus ja niitä sisältävät farmaseuttiset valmisteet
KR950703566A (ko) 티에노디아제핀 화합물 및 그의 의약 용도[thienodiazepine compound and medicinal use thereof]
FI953666L (fi) Hetersykliset yhdisteet ja niiden valmistus ja käyttö
FI942745L (fi) Fluoreeniyhdisteitä ja valmistusmenetelmä
FI954131L (fi) Heterosykliset yhdisteet ja niiden valmistus ja käyttö
FI955899L (fi) Imukykyinen rakenne ja imukykyisen rakenteen sisältävä imukykyinen tuote
FI940640L (fi) Organoaluminoksituotteet ja käyttö
FI932425A7 (fi) Proteaasi ja siihen liittyviä DNA-yhdisteitä
FI954130A7 (fi) Heterosykliset yhdisteet ja niiden valmistus ja käyttö
FI935728A7 (fi) Substituoituja 4-fenyylipyridoneja ja 4-fenyyli-2-alkoksipyridiinejä
FI943313L (fi) Heterosykliset yhdisteet ja niiden valmistus ja käyttö
FI954111A7 (fi) Uudet taksoidit, niiden valmistus ja niitä sisältävät farmaseuttiset v almisteet
FI943508A7 (fi) Pyridiinikarboksimidamidiyhdisteet ja niiden käyttö
FI943734A7 (fi) Uudet makrolidit ja niiden käyttö
FI961938A7 (fi) Uudet taksoidit, niiden valmistus ja niitä sisältävät farmaseuttiset v almisteet
FI900353A7 (fi) Pyrrolidiiniyhdiste ja sen farmaseuttinen käyttö
FI934574A7 (fi) Uusia mikro-orgasmeja ja uusia entsyymejä

Legal Events

Date Code Title Description
HC Name/ company changed in application

Owner name: ROCHE DIAGNOSTICS GMBH

FD Application lapsed